Figure 4.
MAF among patients with IgM monoclonal gammopathy. The mutation detector analysis software revealed the following: IgM-MGUS patients had a median MYD88L265P MAF of 7.74% and 1.6% for tDNA and cfDNA, respectively; aWM patients had a median MAF of 42% and 10% for tDNA and cfDNA; and sWM patients had a median MAF of 84.5% and 26% for tDNA and cfDNA.

MAF among patients with IgM monoclonal gammopathy. The mutation detector analysis software revealed the following: IgM-MGUS patients had a median MYD88L265P MAF of 7.74% and 1.6% for tDNA and cfDNA, respectively; aWM patients had a median MAF of 42% and 10% for tDNA and cfDNA; and sWM patients had a median MAF of 84.5% and 26% for tDNA and cfDNA.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal